Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
23.95
+0.44 (1.87%)
Apr 28, 2026, 3:55 PM EDT - Market open
Kailera Therapeutics Market Cap
Kailera Therapeutics has a market cap or net worth of $2.96 billion as of April 28, 2026.
Market Cap
2.96B
Enterprise Value
2.30B
1-Year Change
n/a
Ranking
Category
Stock Price
23.95
Market Cap Chart
Since the IPO on April 17, 2026, Kailera Therapeutics's market cap has increased from $1.98B to $2.96B, an increase of 49.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.91B | 4.63% |
| Apr 24, 2026 | 2.78B | -10.41% |
| Apr 23, 2026 | 3.10B | 3.21% |
| Apr 22, 2026 | 3.01B | -3.65% |
| Apr 21, 2026 | 3.12B | 2.48% |
| Apr 20, 2026 | 3.04B | 53.81% |
| Apr 17, 2026 | 1.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcutis Biotherapeutics | 2.89B |
| Relay Therapeutics | 2.86B |
| Kodiak Sciences | 2.77B |
| Soleno Therapeutics | 2.73B |
| Beam Therapeutics | 2.72B |
| Vera Therapeutics | 2.70B |
| IDEAYA Biosciences | 2.70B |
| Immunome | 2.67B |